آخر تحديث :
28/04/2024
فرق البحث - University Hospital Jean Verdier, Department of Pharmacy   Pdf  
فرنسا
مستشفى
University Hospital Jean Verdier, Department of Pharmacy
Bondy
مراجع   مراجع   (15)  
1
Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions.
Kabiche D,Balde I.B,Majoul E,Kabiche S,Bourguignon E,Fontan J-E,Cisternino S,Schlatter J. (schlatter@aphp.fr)
Int J Pharm Compound - 2017 - ; 21, 2: 160-163.
2
Stability of Pentobarbital in Water and Oral Pediatric Suspensions.
Schlatter J, Kabiche S, Balde I-S, Majoul E, Cisternino S, Fontan J.E. ()
Ann Pharmacotherapy - 2016 - ; 50: 245-246
3
Stability study of oral paediatric idebenone suspensions.
Schlatter J, Bourguignon E, Majoul E, Kabiche S, Balde I.B, Cisternino S, Fontan J.E. (joel.schlatter@aphp.fr)
Pharm Dev Technol - 2016 -
4
Stability of suxamethonium in pharmaceutical solution for injection by validated stability-indicating chromatographic method.
Beck W, Kabiche S, Balde I-B, Carret S, Fontan J-E, Cisternino S, Schlatter J. (joel.schlatter@aphp.fr)
J Clin Anesth - 2016 - ; 35: 551-559.
5
Stability of Hydrocortisone Preservative-Free Oral Solutions.
Chappe J, Osman N, Cisternino S, Fontan J-E, Schlatter J. (joel. schlatter@jvr.aphp.fr)
J Pediatr Pharmacol Ther - 2015 - ; 20, 3: 197-202.
6
Stability of Betaxolol Suspensions in Oral Syringes and Glass Bottles.
Auvity S, Chiadmi F.M, Cisternino S, Fontan J.E, Schlatter J. (joel.schlatter@jvr.aphp.fr)
Ann Pharmacotherapy - 2013 - ; 47: 1237-1238.
7
Assessment of stability in extemporaneously prepared venlafaxine solutions.
Kervale JG, Castagnet S, Chiadmi F, Schlatter J, Benabadji Z, Cisternino S, Fontan JE. ()
EJHP - 2009 - ; 15, 4: 30-32.
8
Stability of oxaliplatin in infusion bags containing 5% dextrose injection.
André A, Cisternino S, Roy A.L, Chiadmi F, Schlatter J, Agranat P, Fain O, Fontan J.E. (joel.schlatter@jvr.aphp.fr)
Am J Health-Syst Pharm - 2007 - ; 64, 18: 1950-1954.
9
Stability of voriconazole injection in 0.9% sodium chloride and 5% dextrose injections.
Sahraoui L, Chiadmi F, Schlatter J, Toledano A, Cisternino S, Fontan JE. (joel.schlatter@jvr.aphp.fr)
Am J Health-Syst Pharm - 2006 - ; 63: 1423-1426.
10
Stability of bortezomib 1 mg/ml solution in plastic syringe and glass vial.
André P, Cisternino S, Chiadmi F, Toledano A, Schlatter J, Fain O, Fontan JE. (joel.schlatter@jvr.aphp.fr)
Ann Pharmacotherapy - 2005 - ; 39: 1462-1466.
11
Stability of misoprostol in suppositories.
Hafirassou H, Chaidmi F, Schlatter J, Ratiney R, Fontan JE. (joel.schlatter@jvr.aphp.fr)
Am J Health-Syst Pharm - 2005 - ; 62, 11: 1192-1194.
12
Stability of levamisole oral solutions prepared from tablets and powder.
Chiadmi F, Lyer A, Cisternino S et al. ()
J Pharm Pharm Sci - 2005 - ; 8: 322-325.
13
Stability of sulfadiazine oral liquids prepared from tablets and powder.
Pathmanathan U, Halgrain D, Chiadmi F, Schlmatter J, Vermerie N. (joel.schlatter@jvr.ap-hop-paris.fr)
J Pharm Pharm Sci - 2004 - ; 7, 1: 84-87.
14
Stability of cyclophosphamide and mesna admixtures in polyethylene infusion bags.
Menard C, Bourguignon C, Schlatter J, Vermerie N. (joel.schlatter@jvr.aphp.fr)
Ann Pharmacotherapy - 2003 - ; 37, 12: 1789-1792.
15
Stability of fludrocortisone acetate solutions prepared from tablets and powder.
Cisternino S, Schlatter J, Saulnier JL. (joel.schlatter@jvr.aphp.fr)
Eur J Pharm Biopharm - 2003 - ; 55: 209-213.

قائمة المركبات   جزيئات درس   (16)  
المضادة لمستقبلات  البيتا عن طريق الفم  Betaxolol
المضادة للسرطان المخدرات حقن Bortezomib
المضادة للسرطان المخدرات حقن Cyclophosphamide
المضادة للالتهابات عن طريق الفم  Fludrocortisone
المضادة للالتهابات عن طريق الفم  Hydrocortisone sodium succinate
المضادة للسرطان المخدرات عن طريق الفم  Hydroxyurea
مختلف عن طريق الفم  Idebenone
مضاد للطفيليات عن طريق الفم  Levamisol
أدوية حماية الخلايا حقن Mesna
مختلف تحميلة Misoprostol
المضادة للسرطان المخدرات حقن Oxaliplatin
أدوية تخدير عام عن طريق الفم  Pentobarbital sodium
مضاد حيوي عن طريق الفم  Sulfadiazine
 أدوية علاجيه حقن Suxamethonium chloride
المضادة للاكتئاب عن طريق الفم  Venlafaxine
مضاد للفطريات حقن Voriconazole

  Mentions Légales